T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T-cell receptor-based therapy: an innovative therapeutic approach for solid tumors
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 14, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-30
DOI
10.1186/s13045-021-01115-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic engineering of T cells for immunotherapy
- (2021) Gavin I. Ellis et al. NATURE REVIEWS GENETICS
- Promises and challenges of adoptive T-cell therapies for solid tumours
- (2021) Matteo Morotti et al. BRITISH JOURNAL OF CANCER
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- T‐cell receptor affinity in the age of cancer immunotherapy
- (2020) Michele M. Hoffmann et al. MOLECULAR CARCINOGENESIS
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
- (2020) Dennis Huang et al. ADVANCED DRUG DELIVERY REVIEWS
- Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
- (2019) Isabelle Magalhaes et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- MAGE cancer-testis antigens protect the mammalian germline under environmental stress
- (2019) Klementina Fon Tacer et al. Science Advances
- T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance
- (2019) Smita S. Chandran et al. IMMUNOLOGICAL REVIEWS
- T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
- (2019) Stacey L. Doran et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Translating gammadelta (γδ) T cells and their receptors into cancer cell therapies
- (2019) Zsolt Sebestyen et al. NATURE REVIEWS DRUG DISCOVERY
- Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer
- (2019) MIYO ENDO et al. ANTICANCER RESEARCH
- MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
- (2019) Yuan Mao et al. Journal of Hematology & Oncology
- TCR Fingerprinting and Off-Target Peptide Identification
- (2019) Armen R. Karapetyan et al. Frontiers in Immunology
- Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
- (2019) Indu Ramachandran et al. Journal for ImmunoTherapy of Cancer
- Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors
- (2019) Christine Gagliardi et al. CYTOTHERAPY
- Prospective analysis of adoptive TIL therapy in patients with metastatic melanoma: response, impact of anti-CTLA4, and biomarkers to predict clinical outcome
- (2018) Marie-Andrée Forget et al. CLINICAL CANCER RESEARCH
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259 T Cells in Synovial Sarcoma
- (2018) Sandra P. D'Angelo et al. Cancer Discovery
- Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
- (2018) Jonathan Fisher et al. Frontiers in Immunology
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
- (2018) Jennifer N. Brudno et al. BLOOD REVIEWS
- Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
- (2018) Frederick L Locke et al. LANCET ONCOLOGY
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
- (2017) J. Brian Szender et al. GYNECOLOGIC ONCOLOGY
- Engineering Natural Killer Cells for Cancer Immunotherapy
- (2017) Katayoun Rezvani et al. MOLECULAR THERAPY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
- (2017) Shingo Inaguma et al. Oncotarget
- T-cell receptor-engineered T cells for cancer treatment: current status and future directions
- (2017) Yu Ping et al. Protein & Cell
- Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis
- (2016) KRISTIAN MADEIRA et al. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS
- Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
- (2016) R. Andersen et al. CLINICAL CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
- (2016) Paulina J. Paszkiewicz et al. JOURNAL OF CLINICAL INVESTIGATION
- TCR-engineered T cells to treat tumors: Seeing but not touching?
- (2016) Reno Debets et al. SEMINARS IN IMMUNOLOGY
- Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning
- (2016) Kinjal Sanghavi et al. Translational Research
- Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors
- (2016) Daniel T. Harris et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies
- (2016) Yoshio Hagiwara et al. Scientific Reports
- Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding
- (2016) Joseph A. Newman et al. PLoS One
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex
- (2015) Lucie Kozakova et al. CELL CYCLE
- Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
- (2015) Sanja Stevanović et al. JOURNAL OF CLINICAL ONCOLOGY
- NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
- (2015) Aaron P Rapoport et al. NATURE MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- T cell metabolic fitness in antitumor immunity
- (2015) Peter J. Siska et al. TRENDS IN IMMUNOLOGY
- Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
- (2015) E. Sotillo et al. Cancer Discovery
- Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
- (2015) Carin I. M. Dahlberg et al. Frontiers in Immunology
- Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
- (2015) Nu T. Lu et al. Journal for ImmunoTherapy of Cancer
- The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters
- (2015) Marjolaine Ngollo et al. BMC CANCER
- γδT Cells: First Line of Defense and Beyond
- (2014) Yueh-hsiu Chien et al. Annual Review of Immunology
- Neuroblastoma Killing Properties of V 2 and V 2-Negative T Cells Following Expansion by Artificial Antigen-Presenting Cells
- (2014) J. P. H. Fisher et al. CLINICAL CANCER RESEARCH
- A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
- (2014) P. F. Robbins et al. CLINICAL CANCER RESEARCH
- Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
- (2014) James O.J. Davies et al. CYTOTHERAPY
- TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
- (2014) B Berdien et al. GENE THERAPY
- Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions
- (2014) Paul F. Robbins et al. JOURNAL OF IMMUNOLOGY
- IL-2: The First Effective Immunotherapy for Human Cancer
- (2014) S. A. Rosenberg JOURNAL OF IMMUNOLOGY
- Expression of MAGE-A3/6 in Primary Breast Cancer is Associated With Hormone Receptor Negative Status, High Histologic Grade, and Poor Survival
- (2014) Maha Ayyoub et al. JOURNAL OF IMMUNOTHERAPY
- The TCR's sensitivity to self peptide–MHC dictates the ability of naive CD8+ T cells to respond to foreign antigens
- (2014) Ross B Fulton et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
- (2014) Jan Dörrie et al. PLoS One
- Molecular architecture of the αβ T cell receptor–CD3 complex
- (2014) Michael E. Birnbaum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
- (2013) Miroslaw J Szczepanski et al. Biomarkers in Medicine
- Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing
- (2013) Shengli Song et al. Cellular & Molecular Immunology
- Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
- (2013) M. J. Besser et al. CLINICAL CANCER RESEARCH
- Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
- (2013) L. B. John et al. CLINICAL CANCER RESEARCH
- Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma
- (2013) Phyu P. Aung et al. HUMAN PATHOLOGY
- A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4+ T Cells
- (2013) Jun Huang et al. IMMUNITY
- Re-adapting T cells for cancer therapy: from mouse models to clinical trials
- (2013) Ingunn M. Stromnes et al. IMMUNOLOGICAL REVIEWS
- TCR repertoires of intratumoral T-cell subsets
- (2013) Carsten Linnemann et al. IMMUNOLOGICAL REVIEWS
- Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
- (2013) A. G. Chapuis et al. Science Translational Medicine
- Expression and prognostic relevance of PRAME in primary osteosarcoma
- (2012) Pingxian Tan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Challenges in T cell receptor gene therapy
- (2012) Benjamin J. Uttenthal et al. JOURNAL OF GENE MEDICINE
- Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential
- (2012) Megan E. Spurgeon et al. VIROLOGY
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
- (2011) Yuting Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
- (2010) J R Long-Boyle et al. BONE MARROW TRANSPLANTATION
- MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
- (2010) Elke Schultz-Thater et al. INTERNATIONAL JOURNAL OF CANCER
- The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3 Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
- (2010) J. S. Bridgeman et al. JOURNAL OF IMMUNOLOGY
- MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
- (2010) Jennifer M. Doyle et al. MOLECULAR CELL
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
- (2010) Gavin M Bendle et al. NATURE MEDICINE
- Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
- (2009) L. A. Johnson et al. BLOOD
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer
- (2009) Alain Bergeron et al. INTERNATIONAL JOURNAL OF CANCER
- B lymphocytes: how they develop and function
- (2008) T. W. LeBien et al. BLOOD
- Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
- (2008) Mark E. Dudley et al. JOURNAL OF CLINICAL ONCOLOGY
- Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
- (2008) D. C. Palmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
- (2008) D. Atanackovic et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started